-
Je něco špatně v tomto záznamu ?
The Extent of Intracellular Accumulation of Bilirubin Determines Its Anti- or Pro-Oxidant Effect
A. Bianco, A. Dvořák, N. Capková, C. Gironde, C. Tiribelli, C. Furger, L. Vitek, C. Bellarosa
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
NW18-07-00342
Czech Ministry of Health
RVO-VFN64165/2020
Czech Ministry of Health
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2000-03-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2007-01-01
Health & Medicine (ProQuest)
od 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
33143041
DOI
10.3390/ijms21218101
Knihovny.cz E-zdroje
- MeSH
- antioxidancia farmakologie MeSH
- bilirubin farmakologie MeSH
- hepatocelulární karcinom farmakoterapie metabolismus patologie MeSH
- hyperbilirubinemie patofyziologie MeSH
- lidé MeSH
- nádory jater farmakoterapie metabolismus patologie MeSH
- neuroblastom farmakoterapie metabolismus patologie MeSH
- oxidace-redukce MeSH
- oxidační stres účinky léků MeSH
- oxidancia farmakologie MeSH
- reaktivní formy kyslíku metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Severe hyperbilirubinemia can cause permanent neurological damage in particular in neonates, whereas mildly elevated serum bilirubin protects from various oxidative stress-mediated diseases. The present work aimed to establish the intracellular unconjugated bilirubin concentrations (iUCB) thresholds differentiating between anti- and pro-oxidant effects. METHODS: Hepatic (HepG2), heart endothelial (H5V), kidney tubular (HK2) and neuronal (SH-SY5Y) cell lines were exposed to increasing concentration of bilirubin. iUCB, cytotoxicity, intracellular reactive oxygen species (ROS) concentrations, and antioxidant capacity (50% efficacy concentration (EC50)) were determined. RESULTS: Exposure of SH-SY5Y to UCB concentration > 3.6 µM (iUCB of 25 ng/mg) and >15 µM in H5V and HK2 cells (iUCB of 40 ng/mg) increased intracellular ROS production (p < 0.05). EC50 of the antioxidant activity was 21 µM (iUCB between 5.4 and 21 ng/mg) in HepG2 cells, 0.68 µM (iUCB between 3.3 and 7.5 ng/mg) in SH-SY5Y cells, 2.4 µM (iUCB between 3 and 6.7 ng/mg) in HK2 cells, and 4 µM (iUCB between 4.7 and 7.5 ng/mg) in H5V cells. CONCLUSIONS: In all the cell lines studied, iUCB of around 7 ng/mg protein had antioxidant activities, while iUCB > 25 ng/mg protein resulted in a prooxidant and cytotoxic effects. UCB metabolism was found to be cell-specific resulting in different iUCB.
AOP MH2F Team LAAS CNRS 7 avenue de l'Europe 31400 Toulouse France
Department of Life Sciences University of Trieste 34127 Trieste Italy
Italian Liver Foundation Bldg Q AREA Science Park Basovizza SS14 Km 163 5 34149 Trieste Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21011974
- 003
- CZ-PrNML
- 005
- 20210507102739.0
- 007
- ta
- 008
- 210420s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms21218101 $2 doi
- 035 __
- $a (PubMed)33143041
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Bianco, Annalisa $u Italian Liver Foundation (FIF), Bldg Q-AREA Science Park Basovizza, SS14 Km 163,5, 34149 Trieste, Italy $u Department of Life Sciences, University of Trieste, 34127 Trieste, Italy
- 245 14
- $a The Extent of Intracellular Accumulation of Bilirubin Determines Its Anti- or Pro-Oxidant Effect / $c A. Bianco, A. Dvořák, N. Capková, C. Gironde, C. Tiribelli, C. Furger, L. Vitek, C. Bellarosa
- 520 9_
- $a BACKGROUND: Severe hyperbilirubinemia can cause permanent neurological damage in particular in neonates, whereas mildly elevated serum bilirubin protects from various oxidative stress-mediated diseases. The present work aimed to establish the intracellular unconjugated bilirubin concentrations (iUCB) thresholds differentiating between anti- and pro-oxidant effects. METHODS: Hepatic (HepG2), heart endothelial (H5V), kidney tubular (HK2) and neuronal (SH-SY5Y) cell lines were exposed to increasing concentration of bilirubin. iUCB, cytotoxicity, intracellular reactive oxygen species (ROS) concentrations, and antioxidant capacity (50% efficacy concentration (EC50)) were determined. RESULTS: Exposure of SH-SY5Y to UCB concentration > 3.6 µM (iUCB of 25 ng/mg) and >15 µM in H5V and HK2 cells (iUCB of 40 ng/mg) increased intracellular ROS production (p < 0.05). EC50 of the antioxidant activity was 21 µM (iUCB between 5.4 and 21 ng/mg) in HepG2 cells, 0.68 µM (iUCB between 3.3 and 7.5 ng/mg) in SH-SY5Y cells, 2.4 µM (iUCB between 3 and 6.7 ng/mg) in HK2 cells, and 4 µM (iUCB between 4.7 and 7.5 ng/mg) in H5V cells. CONCLUSIONS: In all the cell lines studied, iUCB of around 7 ng/mg protein had antioxidant activities, while iUCB > 25 ng/mg protein resulted in a prooxidant and cytotoxic effects. UCB metabolism was found to be cell-specific resulting in different iUCB.
- 650 _2
- $a antioxidancia $x farmakologie $7 D000975
- 650 _2
- $a bilirubin $x farmakologie $7 D001663
- 650 _2
- $a hepatocelulární karcinom $x farmakoterapie $x metabolismus $x patologie $7 D006528
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hyperbilirubinemie $x patofyziologie $7 D006932
- 650 _2
- $a nádory jater $x farmakoterapie $x metabolismus $x patologie $7 D008113
- 650 _2
- $a neuroblastom $x farmakoterapie $x metabolismus $x patologie $7 D009447
- 650 _2
- $a oxidancia $x farmakologie $7 D016877
- 650 _2
- $a oxidace-redukce $7 D010084
- 650 _2
- $a oxidační stres $x účinky léků $7 D018384
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Dvořák, Aleš $u Institute of Medical Biochemistry and Laboratory Diagnostics, Faculty General Hospital and 1st Faculty of Medicine, Charles University, 121 08 Prague 2, Czech Republic
- 700 1_
- $a Capková, Nikola $u Institute of Medical Biochemistry and Laboratory Diagnostics, Faculty General Hospital and 1st Faculty of Medicine, Charles University, 121 08 Prague 2, Czech Republic
- 700 1_
- $a Gironde, Camille $u AOP/MH2F Team, LAAS-CNRS, 7 avenue de l'Europe, 31400 Toulouse, France
- 700 1_
- $a Tiribelli, Claudio $u Italian Liver Foundation (FIF), Bldg Q-AREA Science Park Basovizza, SS14 Km 163,5, 34149 Trieste, Italy
- 700 1_
- $a Furger, Christophe $u AOP/MH2F Team, LAAS-CNRS, 7 avenue de l'Europe, 31400 Toulouse, France
- 700 1_
- $a Vitek, Libor $u Institute of Medical Biochemistry and Laboratory Diagnostics, Faculty General Hospital and 1st Faculty of Medicine, Charles University, 121 08 Prague 2, Czech Republic $u 4th Department of Internal Medicine, Faculty General Hospital and 1st Faculty of Medicine, Charles University, 121 08 Prague 2, Czech Republic
- 700 1_
- $a Bellarosa, Cristina $u Italian Liver Foundation (FIF), Bldg Q-AREA Science Park Basovizza, SS14 Km 163,5, 34149 Trieste, Italy
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 21, č. 21 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33143041 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507102739 $b ABA008
- 999 __
- $a ok $b bmc $g 1650367 $s 1132353
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 21 $c 21 $e 20201030 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a NW18-07-00342 $p Czech Ministry of Health
- GRA __
- $a RVO-VFN64165/2020 $p Czech Ministry of Health
- LZP __
- $a Pubmed-20210420